Access Keys:
Skip to content (Access Key - 0)



  • Arises from embryonic notochord rests


  • 1-4% of all primary malignant tumors of bone
  • Distribution
    • 50% of tumors of the sacrococcygeal region (excluding metastases)(most common primary malignancy of the sacrum)
    • 50% in sphenooccipital region (clivus)
    • 35% in the sacrum
    • 15% in other vertebra
  • Low grade (most stage IA or IB)


  • Mean age 56 years (sacral), 47 years (other vertebra)
  • 75% have back pain > 6 months
  • ± buttock pain
  • 20% have rectal dysfunction
  • ± constipation
  • ± urinary frequency
  • Presacral mass in all sacral lesions palpable on rectal exam (DON'T BX TRANSRECTUM!)


  • 40-80% calcification: amorphous and peripheral
  • ↑ activity on bone scan
  • MRI superior to CT for local study
  • Metastases to lungs, soft tissues, LN, bone, liver


  • Mucinous, gelatinous with areas of visible hemorrhage


  • Physalipherous cell, with a large vaculated ("bubbly") cytoplasmic component (found in 90% of tumors)
  • "Pink cell" containing pink cytoplasm
  • Cells may be arranged in sheets or cords
  • Immunohistochemistry
    • + mucicarmine, PAS, and alcian blue staining because of hyaluronic acid
    • + S-100 staining
    • + cytokeratin
  • EM: cytoplasmic vacuoles → glycogen


  • Liposarcoma
  • Chondrosarcoma
  • Signet ring-cell carcinoma
  • Metastatic carcinoma (eg, prostate)(when physaliphorous cells are sparse)
  • Ecchordosis (Ecchordosis physaliphora)


  • Complete resection via posterior, simultaneous or sequential anterior/posterior approaches
  • Proximal extent of sacral tumors the most valuable prognostic indicator (S1 worst)
  • En bloc excision even if marginal is tx of choice
  • Has been reported in the mid-cervical spine
  • Bladder and bowel funtion will be impaired if 2nd sacral roots have to be sacrificed, if both spared ? normal control (only certain if both S3 roots preserved)
  • Must include rectum in resection if transrectal bx done
  • ± XRT (≥50 Gy)(proton beam therapy has been advocated)
  • Local recurrence 64% if contaminated margin
  • Too slow growing for chemotx
  • 50-85% 5 year survival mainly due to local structure involvement; 28-43% 10 yr survival
  • Distant metastases may appear >10yrs after the initial resection (lungs, bone, skin, brain, viscera)



  • Development of metastatic disease <1yr after wide resection of primary with a 90% rate of distant spread
  • High grade sarcomatous elements present
  • Higher aneuploid DNA content
  • Tx with chemotx indicated (ifosfamide)



  • Isochromosome 1q as the probable locus involved in susceptibility


Ashwood N, Hoskin PJ, Saunders JI: Metastatic chordoma: pattern of spread and response to chemotherapy. Clin Oncol (R Coll Radiol). 6:341-2,1994.
Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignanni P, Mazzaferro V, Dossena G, Gennari L: Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 37:185-91,1998.
Bas T, Bas P, Prieto M, Ramos V, Bas JL, Espinosa C: A lumbar chordoma treated with a wide resection. Eur Spine J 3:115-7,1994.
Bethke KP, Neifeld JP, Lawrence W Jr: Diagnosis and management of sacrococcygeal chordoma. J Surg Oncol 48:232-8,1991.
Bhadra AK, Casey ATH: Familial chordoma. A report of two cases. JBJS 88B:634-6,2006.
Bianchi PM, Marsella P, Masi R, Andriani G, Tucci FM, Partipilo P, Pierro V: Cervical chordoma in childhood: clinical statistical contribution. Int J Pediatr Otorhinolaryngol 18:39-45,1989.
Bjornsson J, World LE, Ebersold MJ, Laws ER: Chordoma of the mobile spine. A clinicopathological analysis of 40 patients. Cancer 71:735-40,1993.
Boriani S, Chevalley F, Weinstin JN, Biagini R, Campanacci L, Delure F, Piccill P: Chordoma of the spine above the sacrum: treatment and outcome in 21 cases. Spine 21:1569-77,1996.
Cheng EY, Özerdemoglu RA, Transfeldt EE, Thompson RC, Jr: Lumbosacral chordoma: prognostic factors and treatment. Spine 24:1639-45,1999.
Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, Wunder J: Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 41:67-72,1996.
Chandawarkar RY: Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg 20:717-9,1996.
Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr: Lumbosacral chordoma. Prognostic factors and treatment. Spine 24:1639-45,1999.
Currier BL, Todd LT, Maus TP, Fischer DR, Yaszemski MJ: Anatomic relationship of the internal carotid artery to the C1 vertebra: a case report of cervical reconstruction for chordoma and pilot study to assess the risk of screw fixation of the atlas. Spine 28:E461-7,2003.
Dabska M: Parachordoma: a new clinicopathologic entity. Cancer 40:1586-92,1977.
Dalpra I, Malgara R, Miozzo M, : First cytogenetic study of recurrent familial chordoma of the clivus. Int J Cancer 81:24-30,1999.
D'Haen BD, De Jaegere T, Goffin J, Dom R, Demaerel P, Plets C: Chordoma of the lower cervical spine: case report. Clin Neurol Neurosurg 97:245-8,1995.
Doita M, Harada T, Iguchi T, Sumi M, Sha H, Yoshiya S, Kurosaka M: Total sacrectomy and reconstruction for sacral tumors. Spine 28:E296-301,2003.
Enin IP: Chordoma of the nasopharynx in two members of a family. Vestn Otoinolaringol 26:88-90,1964.
Firooznia H, Golimbu C, Rafii M, Reede DL, Kricheff II, Bjorkengren A: Computed tomography of spinal chordomas. J Comput Assist Tomogr 10:45-50,1986.
Firooznia H, Pinto RS, Lin JP, Baruch HH, Zausner J: Chordoma: radiologic evaluation of 20 cases. AJR 127:797-805,1976.
Fisher C, Miettinen M: Parachordoma: a clinicopathologic and immunohistochemical study of four cases of an unusual soft tissue neoplasm. Ann Diagn Pathol1:3-10,1997.
Fleming GF, Heimann PS, Stephens JK, Simon MA, Ferguson MK, Benjamin RS, Samuels BL: Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72:714-8,1993.
Foote RF, Ablin G, Hall WW: Chordoma in siblings. Calif Med 88:383-6,1958.
Fujita T, Kawahara N, Matsumoto T, Tomita K: Chordoma in the cervical spine managed with en bloc excision. Spine 24:1848-51,1999.
Gray SW, Singhbandhu B, Smith RA, Skandalakis JE: Sacrococcygeal chordomas: report of a case and review of the literature. Surg 78:573-82,1975.
Gunterberg B, Norlen L, Stener B, Sundin T: Neurologic evaluation after resection of the sacrum. Invest Urol (Berl): 13:183-8,1975.
Healy JH, Lane JM: Chordoma: a critical review of diagnosis and treatment. Orthop Clin North Am 20:417-26,1989.
Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW: Chordomas and cartilaginous tumours at the skull base. Cancer 32:410-20,1973.
Huang SM, Chen CC, Chiu PC, Lai PH, Ho JT, Tseng HH: Unusual presentation of posterior mediastinal chordoma in a 2-year-old boy. J Pediatr Hematol Oncol 25:743-6,2003.

Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ: Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg 88:1532-1539, 2006.
Jena R, Lubana F, Brooke SL, Geader AR, Jefferies SJ, Burton KE, Laing RJ, Burnet NG: Conformal roation therapy with central axis beam block is a feasible alternative to intensity-modulated radiotherapy for chordomas of the cervical spine. Clin Oncol (R Coll Radiol) 16:449-56,2004.
Kamrin RP, Potanos JN, Pool JL: An evaluation of the diagnosis and treatment of chordoma. J Neurol Neurosurg Psychiatry 27:157-65,1964.
Kelley MJ, Korczak JF, Sheridan E, : Familial chordoma, a tumour of notochordal remnants, is linked to chromosome 7q33. Am J Hum Genet 69:454-60,2001.
Kerr WA, Allen KL, Haynes DR, Sellars SL: Familial nasopharyngeal chordoma. S Afr Med J 49:1584,1975.
Koh PK, Tan BK, Hong SW, Tan MH, Tay AG, Song C, Tan KC: The gluteus maximus muscle flap for reconstruction of sacral chordoma defects. Ann Plast Surg 53:44-9,2004.
Krol G, Sze G, Arbit E, Marcove R, Sundaresan N: Intradural metastases of chordoma. AJNR 10:193-5,1989.
Kuzniacka A, Mertens F, Strombeck B, Wiegant J, Mandahl N: Combined binary ratio labeling fluorescence in situ hybridization analysis of chordoma. Cancer Genet Cytogent 151:178-81,2004.
Manzone P, Fiore N, Forlino D, Alcala M, Cabrera CF: Chordoma of the lumbar L2 vertebra: case report and review of the literature. Eur Spine J 7:252-6,1998.
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM: Chordoma: incidence and survival pattern in the United States, 1973-1995. Cancer Causes Control 12:1-11,2001.
Meyer JE, Lepke RA, Lindfors KK, Pagani JJ, Hirschy JC, Hayman LA, Momose KJ, McGinnis B: Chordomas: Their CT appearance in the cervical, thoracic and lumbar spine. Radiology 153:693-6,1984.
Mindell E: Chordoma. J Bone Joint Surg 63A:501-5,1981.
Miozzo M, Dalpra L, Riva P, : A tumour suppressor locus in familial and sporadic chrodoma maps to 1p36. Int J Cancer 87:68-72,2000.
Mitchell A, Scheithauer BW, Unni KK, Forsyth PJ, Wold LE, McGivney DJ: Chordoma and chondroid neoplasms of the speno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer 72:2943-9,1993.
Murali R, Rovit RL, Benjamin MV: Chordoma of the cervical spine. Neurosurgery 9:253-6,1981.
Noel G, Feuvret L, Ferrand R, Boisserie G, Mazeron JJ, Habrand JL: Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery 55:1252-62,2004.
Ozaki T, Hillmann A, Winkelmann W: Surgical treatment of sacrococcygeal chordoma. J Surg Oncol 64:274-9,1997.
Papagelopoulos PJ, Mavrogenis AF, Galanis EC, Savvidou OD, Boscainos PJ, Katonis PG, Sim FH: Chordoma of the spine: clincicopathological features, diagnosis, and treatment. Orthopedics 27:1256-63,2004.
Rich TA, Schiller A, Suit HD, Mankin HJ: Clinical and pathological review of 48 cases of chordoma. Cancer 56:182-7,1985.
Samson IR, Springfield DS, Suit HD, Mankin HJ: Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg 75A:1476-84,1993.
Sawyer JR, Husain M, Al-Mefty O: Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumours. Neurosurg Focus 10:1-6,2001.
Shimmura Y, Miura K, Yajima S, Tsutsui Y: Sacrococcygeal chordoma in infancy showing an aggressive clinical course: an autopsy case report. Pathol Int 53:473-7,2003.
Soo MY: Chordoma: review of clinicoradiological features and factors affecting survival. Australas Radiol 45:427-34,2001.
Stener, Gunterberg B: High amputation of the sacrum for extirpation of tumors: principles and technique. Spine 3:351-66,1978.
Stepanek J, Cataldo SA, Ebersold MJ, : Familial chordoma with probable autosomal dominant inheritance. Am J Med Genet 75:335-6,1998.
Sundaresan N: Chordomas. Clin Orthop 204:135-42,1986.
Sundaresan N, Boriani S, Rothman A, Holtzman R: Tumors of the osseous spine. J Neurooncol 69:273-90,2004.
Sundaresan N, Galicich JH, Chu FC, Huvos AG: Spinal chordomas. J Neurosurg 50:312-9,1979.
Sundaresan N, Huvos AG, Krol G, Lane JM, Brennan M: Surgical treatment of spinal chordomas. Arch Surg 122:1479-82,1987.
Sung HW, Shu WP, Wang HM, Yuai SY, Tsai YB: Surgical treatment of primary tumors of the sacrum. Clin Orthop 215:91-8,1987.
Todd LT Jr, Yaszemski MJ, Currier BL, Fuchs B, Kim CW, Sim FH: Bowel and bladder function after major sacral resection. Clin Orthop 397:36-9,2002.
Walaas L, Kindblom LG: Fine needle aspiration biopsy in the preoperative diagnosis of chordoma: a study of 17 cases with application of electron microscopic, histochemical and immunocytochemical examination. Hum Pathol 22:22-8,1991.
Yamaguchi T, Suzuki S, Ishiwa H, Shimizu K, Ueda Y: Benign norotchordal cell tumors: a comparative histological study of benign notochrodal cell tumors, classic chordomas, and notochrodal vestiges of fetal intervertebral discs. Am J Surg Pathol 28:756-61,2004.
Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H: The surgical management of sacrococcygeal chordoma. Cancer 85:878-83,1999.
Yuh WT, Lozano RL, Flinckinger FW, Sato Y, Kao SS, Menezes AH: Lumbar epidural chordoma: MR findings. J Comput Assist Tomogr 13:508-10,1989.


Download: PDF | EPUB

Famous Quote
"I am beginning to learn that it is the sweet, simple things of life which are the real ones after all." Laura Ingalls Wilder
Related Content

Resources for Chordoma and related topics on OrthopaedicsOne.